National Cancer Institute
Found 941 results for your search:
Total relevant funding to Prostate for this search:
$240,985,347
Fiscal Year FY 2016
Cancer Type [Prostate]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 941 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies 5P20CA192990-03 $171,681 $103,009 REAMS, ROMONIA FLORIDA AGRICULTURAL AND MECHANICAL UNIV
2
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities 5U54CA143930-07 $730,767 $116,923 FARIAS-EISNER, ROBIN UNIVERSITY OF CALIFORNIA LOS ANGELES
3
(ACN 12011-001-00004) FOR CBRG FOR THE CENTER FOR PROSTATE DISEASE RESEARCH ACN12011001 $459,666 $459,666 UNKNOWN, UNKNOWN UNIFORM THE SERVICES UNIVERSITY OF THE HEALTH
4
(PQ3) AGEs and Race Specific Tumor Immune Response in Prostate Cancer 5R21CA194469-02 $140,445 $140,445 TURNER, DAVID MEDICAL UNIVERSITY OF SOUTH CAROLINA
5
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer 4R01CA180277-04 $307,375 $307,375 LI, XIN NEW YORK UNIVERSITY
6
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment 5R01CA185457-03 $1,005,598 $1,005,598 FRANGIONI, JOHN CURADEL, LLC
7
(PQC4) Habitats in Prostate Cancer 5R01CA190105-03 $682,812 $682,812 GILLIES, ROBERT H. LEE MOFFITT CANCER CTR & RES INST
8
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc 5R01CA185509-03 $258,128 $258,128 GHOSH, PARAMITA UNIVERSITY OF CALIFORNIA AT DAVIS
9
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership 1P20CA202924-01A1 $234,900 $82,215 WILLIAMS, KEVIN NORTH CAROLINA CENTRAL UNIVERSITY
10
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 5P20CA192973-03 $191,836 $95,918 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
11
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies 5P20CA192992-03 $164,190 $114,933 ODEDINA, FOLAKEMI UNIVERSITY OF FLORIDA
12
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership 1P20CA202925-01A1 $259,367 $197,119 PATIERNO, STEVEN DUKE UNIVERSITY
13
2/2 NCCU-LCCC Partnership in Cancer Research 5U54CA156733-07 $997,277 $19,946 EARP, HENRY UNIV OF NORTH CAROLINA CHAPEL HILL
14
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 3P20CA192976-02S1 $20,000 $9,400 MISHRA, MANOJ ALABAMA STATE UNIVERSITY
15
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 5P20CA192976-03 $144,556 $67,941 MISHRA, MANOJ ALABAMA STATE UNIVERSITY
16
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 2U54CA118623-11 $1,134,399 $499,136 TROY, ROBERTA TUSKEGEE UNIVERSITY
17
2016 AUA Urologic Oncology Research Symposium: ""Forging New Paths in Research to Advance Urologic Oncology 1U13CA206383-01 $10,000 $3,400 BEST, CAROLYN AMERICAN UROLOGICAL ASSOCIATION
18
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 2U54CA118948-11 $1,337,658 $361,168 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
19
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 3U54CA118948-11S1 $162,279 $14,605 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
20
3D Prostate Histochemometry to Predict Disease Recurrence 1R01CA197516-01A1 $405,047 $405,047 BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
21
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci 5R21CA191725-02 $185,077 $61,075 FREEDMAN, MATTHEW DANA-FARBER CANCER INST
22
A Mitogen-induced G Protein-coupled Receptor ZIA SC 009389 $134,092 $67,046 Kelly Siebenlist, Kathleen CCR (NCI)
23
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE 3U54CA155496-05S1 $401,250 $112,350 COLDITZ, GRAHAM WASHINGTON UNIVERSITY
24
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials 1R01CA200718-01 $624,044 $624,044 EGGLY, SUSAN WAYNE STATE UNIVERSITY
25
A New Mechanism for Castration Resistant Prostate Cancer 7R01CA166894-04 $368,984 $368,984 SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
26
A New Prostate Cancer Treatment to Improve Outcomes and Reduce Side-effects 1R41CA210737-01 $225,000 $225,000 FLYNN, RYAN PXALPHA, LLC
27
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use 1R01CA207645-01 $555,680 $555,680 WEBER, WOLFGANG SLOAN-KETTERING INST CAN RESEARCH
28
A novel strategy to identify prostate cancer biomarkers for patient management 7R01CA172603-04 $329,925 $329,925 HUANG, JIAOTI DUKE UNIVERSITY
29
A Novel Treatment of Vasomotor Symptoms in Prostate Cancer Patients 1R43CA195910-01A1 $226,310 $226,310 NGUYEN, VIEN AGYPHARMA, LLC
30
A Phase Ib clinical trial with niclosamide plus abiraterone for Castration Resistant Prostate Cancer (CRPC) 1R43CA206668-01 $299,986 $299,986 LIU, CHENGFEI PANDOMEDX, INC.
31
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR 1R01CA200551-01 $247,249 $247,249 PARK, SEAN MAYO CLINIC ROCHESTER
32
A Potent Small Molecule Sigma1 Modulator Degrades Androgen Receptor In Castration Resistant Prostate Cancer 1R43CA206691-01A1 $225,222 $225,222 LEHR, MARTIN CONTEXT THERAPEUTICS, LLC
33
A Randomized Clinical Trial of Exercise for Men with Metastatic Prostate Cancer 5R21CA184605-02 $206,843 $206,843 KENFIELD, STACEY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
34
A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer 1R21CA205108-01 $162,075 $162,075 MOHLER, JAMES ROSWELL PARK CANCER INSTITUTE CORP
35
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors 1R21CA198237-01A1 $202,275 $40,455 DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES
36
AAAPT Technology for Improving Chemotherapy 3R43CA183353-01S1 $40,000 $13,200 PANDURANGI, RAGHU SCI-ENGI-MEDCO SOLUTIONS, INC.
37
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,229,987 $61,499 Sinha, Rashmi DCEG (NCI)
38
Abramson Cancer Center Support Grant 2P30CA016520-40 $7,975,543 $239,266 DANG, CHI UNIVERSITY OF PENNSYLVANIA
39
Abramson Cancer Center Support Grant 3P30CA016520-40S1 $31,250 $938 DANG, CHI UNIVERSITY OF PENNSYLVANIA
40
Abramson Cancer Center Support Grant 3P30CA016520-40S2 $499,967 $14,999 DANG, CHI UNIVERSITY OF PENNSYLVANIA
41
Abramson Cancer Center Support Grant 3P30CA016520-40S3 $200,000 $6,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
42
ACN15005-001-0001 NIST NCI EARLY DETECTION RESEARCH NETWORK: BIOMARKER STANDARDIZATION LABORATORY ACN15005001 $600,000 $600,000 UNKNOWN, UNKNOWN NATIONAL INSTITUTE OF STANDARDS & TECHNOLOGY
43
Activatable molecular cancer imaging probe ZIA BC 011512 $304,350 $60,870 Kobayashi, Hisataka CCR (NCI)
44
Adaptive resistance to HIF1a inhibition in hypoxia 1R01CA207377-01 $352,242 $116,240 QIAN, ZHENG DAVID OREGON HEALTH & SCIENCE UNIVERSITY
45
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI 4R01CA160902-05 $492,649 $492,649 MAIER, STEPHAN BRIGHAM AND WOMEN'S HOSPITAL
46
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention 5K05CA175147-03 $88,959 $88,959 STANFORD, JANET FRED HUTCHINSON CANCER RESEARCH CENTER
47
AIF-mediated Control of Mitochondrial Biogenesis, Metabolism, and Cellular Redox Balance 1R15CA206067-01 $435,000 $435,000 WILKINSON, JOHN NORTH DAKOTA STATE UNIVERSITY
48
Akt isoform-specific signaling in breast cancer metastasis 5R00CA157945-05 $241,629 $60,407 CHIN, YUET MING REBECCA BETH ISRAEL DEACONESS MEDICAL CENTER
49
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S1 $1,595,651 $95,739 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
50
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S2 $550,000 $33,000 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
Total relevant funding to Prostate for this search: $240,985,347
Showing 1 - 50 of 941 results
Go to top